Comparison of Remimazolam Consumption According to Administration Method in Patients Undergoing Cerebrovascular Bypass Surgery: A Prospective Randomized Trial
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this prospective randomized controlled trial is to compare the total consumption of remimazolam between two different administration methods-Target-Controlled Infusion (TCI) and manual infusion-in patients undergoing cerebrovascular bypass surgery.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Patients scheduled to undergo cerebrovascular bypass surgery under general anesthesia.
• American Society of Anesthesiologists (ASA) Physical Status 1, 2, or 3
• Adults aged 19 years or older
• Patients who have provided prior written informed consent to participate in the study
Locations
Other Locations
Republic of Korea
Seoul National University Bundang Hospital
RECRUITING
Seongnam-si
Contact Information
Primary
Chang-Hoon Koo
vollock9@gmail.com
+82317877512
Time Frame
Start Date: 2026-02-04
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 58
Treatments
Experimental: TCI
Remimazolam administered via TCI (target Ce 0.7 μg/mL)
Active_comparator: Manual Infusion
Remimazolam administered via manual infusion (6 mg/kg/hr for induction, 1-2 mg/kg/hr for maintenance)
Related Therapeutic Areas
Sponsors
Leads: Seoul National University Hospital